Your browser doesn't support javascript.
loading
Comparison of tamsulosin and silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia in patients planned for trial without catheter. A prospective randomized study.
Patil, Siddangouda B; Ranka, Kshitiz; Kundargi, Vinay S; Guru, Nilesh.
Afiliación
  • Patil SB; Department of urology, BLDEU'S Shri B.M. Patil Medical College, hospital and research centre, Bijapur, India.
  • Ranka K; Department of urology, BLDEU'S Shri B.M. Patil Medical College, hospital and research centre, Bijapur, India.
  • Kundargi VS; Department of urology, BLDEU'S Shri B.M. Patil Medical College, hospital and research centre, Bijapur, India.
  • Guru N; Department of urology, BLDEU'S Shri B.M. Patil Medical College, hospital and research centre, Bijapur, India.
Cent European J Urol ; 70(3): 259-263, 2017.
Article en En | MEDLINE | ID: mdl-29104788
INTRODUCTION: We present a prospective randomized study to compare the efficacy of tamsulosin and silodosin in patients suffering from acute urinary retention caused by benign prostatic hyperplasia, planned for trial without catheter. MATERIAL AND METHODS: Patients with acute urinary retention secondary to benign prostatic hyperplasia (total 160) were catheterized and randomized into two groups: Group A: tamsulosin 0.4 mg (80 patients) and Group B: silodosin 8 mg (80 patients). After three days, the catheter was removed, and patients were put on trial without catheter. Patients with a successful trial without catheter were followed up after two weeks and one month, taking into account the international prostate symptom score (IPSS), post void residual volume (PVR), and peak flow rate (PFR). Statistical analysis of the data was performed. RESULTS: Both group A (tamsulosin) and group B (silodosin) had similar results of trial without catheter (group A: 67.50%, group: B 60%). In follow up, three patients in group A and four patients in group B had retention of urine, requiring recatheterization. These patients were withdrawn from the study. No significant differences were present between group A and group B patients in regard with IPSS, PVR and PFR measured at the time of successful trial without catheter and during follow up at two weeks and one month. CONCLUSIONS: Efficacy for trial without catheter of tamsulosin was slightly higher than silodosin, but comparable. No statistical difference between tamsulosin & silodosin treated groups were found in regard with IPSS, PVR and PFR.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Cent European J Urol Año: 2017 Tipo del documento: Article País de afiliación: India Pais de publicación: Polonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Cent European J Urol Año: 2017 Tipo del documento: Article País de afiliación: India Pais de publicación: Polonia